Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesus D Gonzalez-Lugo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Hematology. American Society of Hematology. Education Program|December 9, 2022
Targeting inflammation in lower-risk MDSJesus D Gonzalez-Lugo, Amit Verma
Seminars in Hematology|January 29, 2021
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemiaJesus D Gonzalez-Lugo, Samarpana Chakraborty, Amit Verma, et al.
Thrombosis Research|January 1, 2019
Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort studyAna Acuna-Villaorduna, Vivy Tran, Jesus D Gonzalez-Lugo, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 12, 2021
Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 PatientsJoseph M Sweeney, Mohammad Barouqa, Gregory J Krause, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2020
Evidence for secondary thrombotic microangiopathy in COVID-19Joseph M Sweeney, Mohammad Barouqa, Gregory J Krause, et al.
Frontiers in Physiology|March 12, 2021
Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational CohortMorayma Reyes Gil, Jesus D Gonzalez-Lugo, Shafia Rahman, et al.
Thrombosis and Haemostasis|November 13, 2020
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on MortalityHenny H Billett, Morayma Reyes-Gil, James Szymanski, et al.
Frontiers in Oncology|April 26, 2024
Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic reviewPolina Bellman, Jesus D Gonzalez-Lugo, Moazzam Shahzad, et al.
Critical Reviews in Oncology/Hematology|February 29, 2024
Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysisMoazzam Shahzad, Qamar Iqbal, Ezza Tariq, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical TrialJesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Hematology. American Society of Hematology. Education Program|December 9, 2022
Targeting inflammation in lower-risk MDSJesus D Gonzalez-Lugo, Amit Verma
Seminars in Hematology|January 29, 2021
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemiaJesus D Gonzalez-Lugo, Samarpana Chakraborty, Amit Verma, et al.
Thrombosis Research|January 1, 2019
Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort studyAna Acuna-Villaorduna, Vivy Tran, Jesus D Gonzalez-Lugo, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|March 12, 2021
Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 PatientsJoseph M Sweeney, Mohammad Barouqa, Gregory J Krause, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2020
Evidence for secondary thrombotic microangiopathy in COVID-19Joseph M Sweeney, Mohammad Barouqa, Gregory J Krause, et al.
Frontiers in Physiology|March 12, 2021
Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational CohortMorayma Reyes Gil, Jesus D Gonzalez-Lugo, Shafia Rahman, et al.
Thrombosis and Haemostasis|November 13, 2020
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on MortalityHenny H Billett, Morayma Reyes-Gil, James Szymanski, et al.
Frontiers in Oncology|April 26, 2024
Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic reviewPolina Bellman, Jesus D Gonzalez-Lugo, Moazzam Shahzad, et al.
Critical Reviews in Oncology/Hematology|February 29, 2024
Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysisMoazzam Shahzad, Qamar Iqbal, Ezza Tariq, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical TrialJesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, et al.
Pageof 2